Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ceforanide: in vitro and clinical evaluation.

K H Burch, D Pohlod, L D Saravolatz

    Antimicrobial Agents and Chemotherapy
    |September 1, 1979
    PubMed
    Summary

    Ceforanide, a novel cephalosporin antibiotic, demonstrates broad-spectrum antimicrobial activity and favorable clinical efficacy in treating various infections. This new antibiotic, administered twice daily, was well-tolerated by patients.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Molecular signatures of maladaptive plasticity in the amygdala in a rat model of chronic neuropathic pain.

    bioRxiv : the preprint server for biology·2026
    Same author

    Functional characterization of complete and immunodominant epitopes of a novel pollen allergen from Parthenium hysterophorus.

    European annals of allergy and clinical immunology·2024
    Same author

    Toward Programmable Quantum Processors Based on Spin Qubits with Mechanically Mediated Interactions and Transport.

    Physical review letters·2024
    Same author

    Numerical Optimization of a Nanophotonic Cavity by Machine Learning for Near-Unity Photon Indistinguishability at Room Temperature.

    ACS photonics·2022
    Same author

    Clinical Characteristics in Patients with Rheumatoid Arthritis: Differences between Genders.

    TheScientificWorldJournal·2019
    Same author

    Postantibiotic effect and postantibiotic sub-MIC effect of LTX-109 and mupirocin on Staphylococcus aureus blood isolates.

    Letters in applied microbiology·2017

    Area of Science:

    • Infectious Diseases
    • Pharmacology
    • Microbiology

    Background:

    • Ceforanide is a novel cephalosporin antibiotic characterized by a prolonged half-life, enabling twice-daily dosing.
    • Evaluating new antimicrobial agents is crucial for combating evolving infectious diseases.

    Purpose of the Study:

    • To assess the antimicrobial activity, pharmacokinetic profile, and clinical effectiveness of ceforanide.
    • To determine the efficacy of ceforanide in treating various bacterial infections.

    Main Methods:

    • In vitro susceptibility testing of clinical isolates against ceforanide.
    • Clinical evaluation of ceforanide in 27 patients with diverse bacterial infections, administered intramuscularly or intravenously.
    • Pharmacokinetic analysis including peak plasma concentrations and half-life determination.

    Related Experiment Videos

    Main Results:

    • Ceforanide exhibited activity against cephalothin-susceptible gram-positive and gram-negative bacteria.
    • The antibiotic effectively inhibited cephalothin-resistant Escherichia coli and Enterobacter species.
    • Satisfactory clinical and bacteriological responses were observed in 100% and 96% of patients, respectively.
    • Ceforanide was generally well-tolerated, with mild, transient elevations in liver enzymes and eosinophilia reported in a few cases.

    Conclusions:

    • Ceforanide is a promising new cephalosporin antibiotic with broad-spectrum activity and good clinical efficacy.
    • Its favorable pharmacokinetic profile and tolerability support its use in treating susceptible bacterial infections.
    • Further investigation into potential rare adverse effects, such as significant liver enzyme elevations, is warranted.